Breaking News

First AxioMed Viscoelastic Total Disc Replacement Implanted in Australia

By PR Web | May 19, 2017

The next-generation disc replacement restores natural disc height, lordosis, stability and spinal motion.

AxioMed's Viscoelastic Total Disc Replacement has made its debut in Australia.

Dr. Ralph Mobbs of the Neuro Spine Clinic implanted the product on April 28 at the Prince Of Wales Private Hospital. The procedure—the continent's first involving the viscoelastic disc replacement—was performed on a 46-year-old male patient suffering from a degenerative cervical disc at level C6-C7. The patient failed conservative treatments prior to undergoing surgery.
The AxioMed viscoelastic disc is a next-generation disc replacement that restores natural disc height, lordosis, stability and motion in the human spine. AxioMed was approved in 2016 to market and sell its viscoelastic cervical and lumbar Freedom total disc replacements in Australia by the Therapeutic Goods Administration.
Mobbs spoke to the advantages of the AxioMed cervical disc after the operation, stating, “The Freedom Cervical Disc is a new and innovative treatment that I’ve been eager to use. I found the prosthesis matched the patient’s anatomy well, restored disc height and fit very well within the intervertebral space. The disc was easily placed with AxioMed’s simple and effective instrumentation. I believe in this viscoelastic technology and its benefits and I look forward to using the Freedom Cervical Disc to treat my patients in the future.”
AxioMed CEO Dr. Kingsley R. Chin explained how an experience like Dr. Mobbs’ aligns with AxioMed’s vision. “AxioMed believes it can replicate the success of total joint restoration in the spine with our innovative and advanced viscoelastic total disc replacements with a high degree of patient satisfaction,” he said. “With the addition of the lateral lumbar technique, we expect AxioMed to be the worldwide leader in disc replacement surgery.”
Mobbs currently practices neurosurgery with a special interest in minimally invasive and complex spine surgery.
Founded in 2001, AxioMed began its journey of proving the Freedom Disc through clinical studies in the United States and Europe, research, development, and testing. In 2014, KICVentures recognized the disc’s potential and acquired the company into its healthcare portfolio. AxioMed owns an exclusive viscoelastic material license on its proprietary Freedom Disc technology. The company is based in Malden, Mass.

Related News:

Related Markets:

  • Loading Orthopedic Devices with Biologics and Pharmaceuticals

    Loading Orthopedic Devices with Biologics and Pharmaceuticals

    Dr. Kevin Nelson, Founder and CSO, TissueGen Inc.||May 19, 2017
    Fiber technology enables the delivery of the therapeutic components via a biodegradable platform that can be implanted.

  • Looking Beneath the Surface

    Looking Beneath the Surface

    Sam Brusco, Associate Editor||May 19, 2017
    Surface treatments seek to improve orthopedic device usability, longevity, and bone integration.

  • Going to Extremes

    Going to Extremes

    Michael Barbella, Managing Editor||May 19, 2017
    The innovation and market value found in extremity solutions is prompting a change of heart among major orthopedic firms.